Jump Financial, LLC Rocket Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$15.07 - $24.05 $72,562 - $115,800	-4,815 Reduced 10.87%	39,463 $808,000
Q3 2023 Nov 07, 2023	BUY	$15.07 - $24.05 $594,707 - $949,085	39,463 New	39,463 $808,000
Q1 2023 Oct 21, 2024	BUY	$15.79 - $22.6 $699,149 - $1 Million	44,278 New	44,278 $758,000
Q1 2023 May 03, 2023	BUY	$15.79 - $22.6 $699,149 - $1 Million	44,278 New	44,278 $758,000
Q2 2022 Aug 09, 2022	SELL	$7.96 - $16.64 $128,156 - $267,904	-16,100 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$13.16 - $23.68 $138,180 - $248,640	-10,500 Reduced 39.47%	16,100 $255,000
Q4 2021 Feb 10, 2022	BUY	$21.52 - $36.02 $572,432 - $958,132	26,600 New	26,600 $581,000

210

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $788M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.